Who May Qualify for a GLP-1 Lawsuit You may qualify for a GLP-1 injury claim if you meet the following criteria: Medication: Use of a brand-name GLP-1 drug Ozempic, Wegovy, Mounjaro, Trulicity, or Rybelsus Duration: Used the medication for at least 23 months Purpose: Prescribed for weight loss or diabetes Injury: Gastroparesis a condition characterized by partial or complete paralysis of the stomach, leading to delayed gastric emptying Severe intestinal obstruction (ileus) a disruption of normal bowel function causing significant blockage of the intestines Gallbladder disease resulting in cholecystectomy (surgical removal of the gallbladder) prior to 2022 Treatment: Emergency room or hospital visit required Common GLP-1 Side Effects and Injuries While many patients tolerate GLP-1 receptor agonists well, others experience debilitating side effects such as chronic nausea, vomiting, abdominal pain, dehydration, and severe gastrointestinal distress
30% of younger Britons and 18% of younger Americans reported improved energy levels 22% of older Britons and 19% of younger Americans noted improved mood or reduced anxiety
Individual results vary based on factors like age, baseline hormone levels, lifestyle habits, and adherence to the treatment protocol
As clamp-derived measures of hepatic or peripheral insulin sensitivity were lacking, we had limited power to detect small changes in insulin sensitivity
However, the molecular mechanisms of hepatic steatosis occurrence and progression are poorly understood
